Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase NA 4Phase 1/2 3Phase 4 2Phase 2 2Phase 2/3 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Classical hematology 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Thrombosis 1Pulmonary Embolism 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Heparin, Low-Molecular-Weight × Clear all
NCT05498428 2026-06-05

PALOMA-2

Janssen Research & Development, LLC

Phase 2 Recruiting
520 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01817257 2018-10-29

ALICAT

Cardiff University

Phase 2 Terminated
2 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡